A method for improving the survival rate of a patient exposed to an endotoxin, the method comprising the step of administering tumor cytotoxic factor II intravenously, intramuscularly or subcutaneously to said patient in an amount effective to improve the survival rate of said patient, wherein the TCF II is administered before or after said {HEAD ~ patient} is exposed to {TAIL ~ an endotoxin} 
is exposed to
A method for improving the survival rate of a patient exposed to an endotoxin , the method comprising the step of administering tumor cytotoxic factor II intravenously , intramuscularly or subcutaneously to said patient in an amount effective to improve the survival rate of said patient , wherein the TCF II is administered before or after said { HEAD ~ patient } is exposed to { TAIL ~ an endotoxin }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD REL REL REL TAIL TAIL TAIL TAIL TAIL TAIL